中国医药
中國醫藥
중국의약
CHINA MEDICINE
2015年
6期
861-864
,共4页
陈少斌%翁鸿锐%王耿%刘迪填%李桦%杨捷生%杨卫平%陈于平
陳少斌%翁鴻銳%王耿%劉迪填%李樺%楊捷生%楊衛平%陳于平
진소빈%옹홍예%왕경%류적전%리화%양첩생%양위평%진우평
食管胃结合部腺癌%胃泌素受体%免疫组织化学
食管胃結閤部腺癌%胃泌素受體%免疫組織化學
식관위결합부선암%위비소수체%면역조직화학
Adenocarcinoma of esophagogastric junction%Gastrin receptor%Immunohistochemistry
目的 探索食管胃结合部腺癌组织中胃泌素受体的表达及其临床意义.方法 收集汕头大学医学院附属肿瘤医院2011年10月至2014年6月行食管胃结合部腺癌根治术患者120例,男101例,女19例;年龄40 ~ 82岁,中位年龄64岁.应用免疫组织化学技术检测手术切除癌组织和相邻正常胃黏膜胃泌素受体的表达情况.分析胃泌素受体表达与临床病理因素的相关性.结果 120例患者中,癌组织胃泌素受体阴性18例,弱阳性39例,中阳性47例,强阳性16例;正常胃黏膜组织中,胃泌素受体表达多为阴性或弱阳性,仅19例为中阳性.胃泌素受体表达与患者性别、年龄、吸烟、饮酒、肿瘤细胞分化程度及pT分级等无明显相关性(P>0.05).胃泌素受体表达阳性在pN分级0、1~3级患者中分别为32.3% (10/31)、59.6%(53/89),在pTNM分期Ⅰ~Ⅱ、Ⅲ期患者中分别为34.6%(9/26)、57.4%(54/94),胃泌素受体表达与pN分级及pTNM分期呈正相关(P<0.05).结论 胃泌素受体在食管胃结合部腺癌组织中表达率较高,并且随着肿瘤的进展胃泌素受体表达率也升高,有望成为食管胃结合部腺癌的一个治疗靶点.
目的 探索食管胃結閤部腺癌組織中胃泌素受體的錶達及其臨床意義.方法 收集汕頭大學醫學院附屬腫瘤醫院2011年10月至2014年6月行食管胃結閤部腺癌根治術患者120例,男101例,女19例;年齡40 ~ 82歲,中位年齡64歲.應用免疫組織化學技術檢測手術切除癌組織和相鄰正常胃黏膜胃泌素受體的錶達情況.分析胃泌素受體錶達與臨床病理因素的相關性.結果 120例患者中,癌組織胃泌素受體陰性18例,弱暘性39例,中暘性47例,彊暘性16例;正常胃黏膜組織中,胃泌素受體錶達多為陰性或弱暘性,僅19例為中暘性.胃泌素受體錶達與患者性彆、年齡、吸煙、飲酒、腫瘤細胞分化程度及pT分級等無明顯相關性(P>0.05).胃泌素受體錶達暘性在pN分級0、1~3級患者中分彆為32.3% (10/31)、59.6%(53/89),在pTNM分期Ⅰ~Ⅱ、Ⅲ期患者中分彆為34.6%(9/26)、57.4%(54/94),胃泌素受體錶達與pN分級及pTNM分期呈正相關(P<0.05).結論 胃泌素受體在食管胃結閤部腺癌組織中錶達率較高,併且隨著腫瘤的進展胃泌素受體錶達率也升高,有望成為食管胃結閤部腺癌的一箇治療靶點.
목적 탐색식관위결합부선암조직중위비소수체적표체급기림상의의.방법 수집산두대학의학원부속종류의원2011년10월지2014년6월행식관위결합부선암근치술환자120례,남101례,녀19례;년령40 ~ 82세,중위년령64세.응용면역조직화학기술검측수술절제암조직화상린정상위점막위비소수체적표체정황.분석위비소수체표체여림상병리인소적상관성.결과 120례환자중,암조직위비소수체음성18례,약양성39례,중양성47례,강양성16례;정상위점막조직중,위비소수체표체다위음성혹약양성,부19례위중양성.위비소수체표체여환자성별、년령、흡연、음주、종류세포분화정도급pT분급등무명현상관성(P>0.05).위비소수체표체양성재pN분급0、1~3급환자중분별위32.3% (10/31)、59.6%(53/89),재pTNM분기Ⅰ~Ⅱ、Ⅲ기환자중분별위34.6%(9/26)、57.4%(54/94),위비소수체표체여pN분급급pTNM분기정정상관(P<0.05).결론 위비소수체재식관위결합부선암조직중표체솔교고,병차수착종류적진전위비소수체표체솔야승고,유망성위식관위결합부선암적일개치료파점.
Objective To investigate the expression and the clinical significance of gastrin receptor in adenocarcinoma of esophagogastric junction (AEG).Methods Totally 120 AEG patients confirmed by pathology who underwent surgical resection from October 2011 to June 2014 were collected.Immunohistochemistry was used to assess the expression of gastrin receptor in tumor tissue and adjacent normal tissue.The correlation between gastrin receptor expression and clinicopathologic features was analyzed.Results Of the 120 patients with AEG,gastrin receptor in tumor tissue was negatively expressed in 18 cases,weakly positively expressed in 39 cases,moderately positively expressed in 47 cases,and strongly positively expressed in 16 cases;most of normal tissue showed negative or weakly positive expression of gastrin;only 19 showed moderately positive expression of gastrin receptor.The expression of gastrin receptor was not significantly different between male and female,≤60 and >60 years old,smokers and non smokers,alcohol users and non alcohol users,pT grade 1-2 and 3-4 patients;there were no significant differences among patients with low,moderate and high differentiation of tumor (P > 0.05).The expression of gastrin receptor was significantly different between pN grade 0 and 1-3 patients [32.3% (10/31) vs 59.6% (53/89)],and between pTNM stage Ⅰ-Ⅱ and Ⅲ patients [34.6% (9/26) vs 57.4% (54/94)] (P =0.05).Conclusion Gastrin receptor is over-expressed in AEG and the expression level is increased with tumor progression.